mp.weixin.qq.com· 华创新药·· 11 days agoScore21
Lilly and Novo Nordisk Find GLP-1 Drugs Slow Molecular Markers of Aging
In brief
Eli Lilly and Novo Nordisk report that patients taking their GLP-1 drugs for overweight or diabetes aged more slowly than placebo patients, according to molecular "aging clock" readings. Both companies found biological age was reduced with GLP-1 treatment, though the difference varied greatly depending on the type of clock and the organ tested.
Source: mp.weixin.qq.com